(Total Views: 283)
Posted On: 05/02/2017 1:34:09 PM
Post# of 15624
Well, the Topical Creams is what's launching first.
Psoriasis first, of course. But it's quite clear they'll have different cream variations for "other skin conditions and disorders" -- which we'll hear more about in the coming month or two.
Beyond that, the Sublingual Tablet is also "ready", just has to be associated first with a specific condition first -- which I think it's quite obvious they'll focus on Fibromyalgia first.
Finally, the thing that could be the biggest Game Changer (in my opinion) would be the Multiple Myeloma research as they'll try for Orphan Drug status that would allow for FDA Fast Track approval.
Psoriasis first, of course. But it's quite clear they'll have different cream variations for "other skin conditions and disorders" -- which we'll hear more about in the coming month or two.
Beyond that, the Sublingual Tablet is also "ready", just has to be associated first with a specific condition first -- which I think it's quite obvious they'll focus on Fibromyalgia first.
Finally, the thing that could be the biggest Game Changer (in my opinion) would be the Multiple Myeloma research as they'll try for Orphan Drug status that would allow for FDA Fast Track approval.
(2)
(0)
